Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Eric A. Collisson"'
Autor:
Man-Tzu Wang, Nicole Fer, Jacqueline Galeas, Eric A. Collisson, Sung Eun Kim, Jeremy Sharib, Frank McCormick
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
KRAS mutations are frequent in pancreatic ductal adenocarcinoma, leading to bad prognosis and resistance to targeted therapies. Here, the authors show that LIF expression is specifically induced by KRAS and constitutes a potential target to treat the
Externí odkaz:
https://doaj.org/article/1264485d73e0466695383206f5054dba
Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
Autor:
Jian Carrot-Zhang, Xiaotong Yao, Siddhartha Devarakonda, Aditya Deshpande, Jeffrey S. Damrauer, Tiago Chedraoui Silva, Christopher K. Wong, Hyo Young Choi, Ina Felau, A. Gordon Robertson, Mauro A.A. Castro, Lisui Bao, Esther Rheinbay, Eric Minwei Liu, Tuan Trieu, David Haan, Christina Yau, Toshinori Hinoue, Yuexin Liu, Ofer Shapira, Kiran Kumar, Karen L. Mungall, Hailei Zhang, Jake June-Koo Lee, Ashton Berger, Galen F. Gao, Binyamin Zhitomirsky, Wen-Wei Liang, Meng Zhou, Sitapriya Moorthi, Alice H. Berger, Eric A. Collisson, Michael C. Zody, Li Ding, Andrew D. Cherniack, Gad Getz, Olivier Elemento, Christopher C. Benz, Josh Stuart, J.C. Zenklusen, Rameen Beroukhim, Jason C. Chang, Joshua D. Campbell, D. Neil Hayes, Lixing Yang, Peter W. Laird, John N. Weinstein, David J. Kwiatkowski, Ming S. Tsao, William D. Travis, Ekta Khurana, Benjamin P. Berman, Katherine A. Hoadley, Nicolas Robine, Matthew Meyerson, Ramaswamy Govindan, Marcin Imielinski
Publikováno v:
Cell Reports, Vol 34, Iss 8, Pp 108784- (2021)
Externí odkaz:
https://doaj.org/article/4264da604a8b4596a7e8b99d914ad26d
Autor:
Dominic Amara, BA, Steven A. Wisel, MD, Hillary J. Braun, MD, Eric A. Collisson, MD, Terence Friedlander, MD, Giulia Worner, NP, Garret R. Roll, MD, Ryutaro Hirose, MD, Peter G. Stock, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 1, p e636 (2021)
Background. Stopping immunosuppression in a transplant patient with donor-derived malignancy offers the theoretical benefit that reconstitution of the patient’s immune system will allow “rejection” of the malignancy, as the malignancy also orig
Externí odkaz:
https://doaj.org/article/ec72f01d968d4fe98ccf841a9899fd32
Autor:
Jeffrey P. North, Justin Golovato, Charles J. Vaske, J. Zachary Sanborn, Andrew Nguyen, Wei Wu, Benjamin Goode, Meredith Stevers, Kevin McMullen, Bethany E. Perez White, Eric A. Collisson, Michele Bloomer, David A. Solomon, Stephen C. Benz, Raymond J. Cho
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-9 (2018)
Sebaceous carcinomas (SeC) are cutaneous malignancies that sometimes metastasize and cause death. Here the authors perform whole-exome sequencing on 32 SeC and report distinct mutational classes that may explain cancer ontogeny and clinical outcome.
Externí odkaz:
https://doaj.org/article/a7a23b1126f944b2aad81a9029010a17
Autor:
Christina L. Zheng, Nicholas J. Wang, Jongsuk Chung, Homayoun Moslehi, J. Zachary Sanborn, Joseph S. Hur, Eric A. Collisson, Swapna S. Vemula, Agne Naujokas, Kami E. Chiotti, Jeffrey B. Cheng, Hiva Fassihi, Andrew J. Blumberg, Celeste V. Bailey, Gary M. Fudem, Frederick G. Mihm, Bari B. Cunningham, Isaac M. Neuhaus, Wilson Liao, Dennis H. Oh, James E. Cleaver, Philip E. LeBoit, Joseph F. Costello, Alan R. Lehmann, Joe W. Gray, Paul T. Spellman, Sarah T. Arron, Nam Huh, Elizabeth Purdom, Raymond J. Cho
Publikováno v:
Cell Reports, Vol 9, Iss 4, Pp 1228-1234 (2014)
Somatic mutations in cancer are more frequent in heterochromatic and late-replicating regions of the genome. We report that regional disparities in mutation density are virtually abolished within transcriptionally silent genomic regions of cutaneous
Externí odkaz:
https://doaj.org/article/4bc447746133449a9b036da17031b264
Autor:
Eric A. Collisson, AmirAli Talasaz, Pamela N. Munster, Trever G. Bivona, Margaret A. Tempero, Andrew H. Ko, Katherine Van Loon, Robin K. Kelley, Chloe E. Atreya, Zhen Wang, Andrew E. Hendifar, Mary Vu, Jim Leng, Lai Mun Siew, Dragan Sebisanovic, Claire Greene, Oliver A. Zill
Tumor marker levels and cfDNA mutant allele fractions across 19 time intervals for eight patients that were serially monitored via blood draws.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61b33082c375d2591fee9c8fe16cb14
https://doi.org/10.1158/2159-8290.22530579
https://doi.org/10.1158/2159-8290.22530579
Autor:
Eric A. Collisson, AmirAli Talasaz, Pamela N. Munster, Trever G. Bivona, Margaret A. Tempero, Andrew H. Ko, Katherine Van Loon, Robin K. Kelley, Chloe E. Atreya, Zhen Wang, Andrew E. Hendifar, Mary Vu, Jim Leng, Lai Mun Siew, Dragan Sebisanovic, Claire Greene, Oliver A. Zill
Complete patient-level and mutation-level concordance information, mutation identities, and monitoring status for each patient in study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab3c361da8b38493344f145b6642aa0
https://doi.org/10.1158/2159-8290.22530582.v1
https://doi.org/10.1158/2159-8290.22530582.v1
Autor:
W. Michael Korn, Andrew H. Ko, Yun K. Hom, Byron Hann, Peter M. Schaefer, Eric A. Collisson, Olga K. Mirzoeva
PDF - 1610K, List of Predictors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60dd8467aecd85fee3070d2e589528a7
https://doi.org/10.1158/1535-7163.22498783
https://doi.org/10.1158/1535-7163.22498783
Autor:
W. Michael Korn, Andrew H. Ko, Yun K. Hom, Byron Hann, Peter M. Schaefer, Eric A. Collisson, Olga K. Mirzoeva
PDF - 47K, Legends for Supplementary Figures 1-3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc1b37b7b3e6d28bbd917193a7cf0b9
https://doi.org/10.1158/1535-7163.22498786.v1
https://doi.org/10.1158/1535-7163.22498786.v1
Autor:
W. Michael Korn, Andrew H. Ko, Yun K. Hom, Byron Hann, Peter M. Schaefer, Eric A. Collisson, Olga K. Mirzoeva
PDF - 968K, Western blot analysis of the biochemical response of two epithelial (HPAF-II and Panc10.05) and two mesenchymal (Panc2.13 and PA-TU8988T) PDAC cell lines treated with MEK inhibitor CI1040 in the presence or absence of ZEB1 knockdown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9730fa3d82b6a6e682548e5130a77d3b
https://doi.org/10.1158/1535-7163.22498789.v1
https://doi.org/10.1158/1535-7163.22498789.v1